메뉴 건너뛰기




Volumn 111, Issue 11, 1999, Pages 439-442

Efficacy of fluoxetine in Austrian patients with obsessive-compulsive disorder

Author keywords

Double blind; Fluoxetine; Obsessive compulsive disorder; Placebo

Indexed keywords

FLUOXETINE;

EID: 0033522868     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (21)

References (29)
  • 1
    • 0024205564 scopus 로고
    • The epidemiology of obsessive-compulsive disorder in five US communities
    • Karno M, Golding JM, Sorenson SB, Burman MA (1988) The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 45: 1094-1099
    • (1988) Arch Gen Psychiatry , vol.45 , pp. 1094-1099
    • Karno, M.1    Golding, J.M.2    Sorenson, S.B.3    Burman, M.A.4
  • 2
    • 0022501517 scopus 로고
    • Clinical characteristics and family history in DSM-III obsessive-compulsive disorder
    • Rasmussen SA, Tsuang MT (1986) Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry 143: 317-322
    • (1986) Am J Psychiatry , vol.143 , pp. 317-322
    • Rasmussen, S.A.1    Tsuang, M.T.2
  • 3
    • 0026410690 scopus 로고
    • Clomipramine in the treatment of patients with obsessive-compulsive disorder
    • Clomipramine Collaborative Study Group
    • Clomipramine Collaborative Study Group (1991) Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 48: 730-738
    • (1991) Arch Gen Psychiatry , vol.48 , pp. 730-738
  • 4
    • 0344532729 scopus 로고
    • Chlorpromazine in obsessive compulsive and allied disorders
    • Trethowan JWH, Scott PAL (1955) Chlorpromazine in obsessive compulsive and allied disorders. Lancet: 781-785
    • (1955) Lancet , pp. 781-785
    • Trethowan, J.W.H.1    Scott, P.A.L.2
  • 5
    • 0014131311 scopus 로고
    • Treatment of the phobic obsessive compulsive patient with oxazepam, an improved benzodi-azepine compound
    • Orvin GH (1967) Treatment of the phobic obsessive compulsive patient with oxazepam, an improved benzodi-azepine compound. Psychosomatics 8: 278-280
    • (1967) Psychosomatics , vol.8 , pp. 278-280
    • Orvin, G.H.1
  • 6
    • 0344101309 scopus 로고
    • A controlled trial with valium in obsessive compulsive states
    • Rao AV (1964) A controlled trial with valium in obsessive compulsive states. J Indian Med Assoc 42: 564-567
    • (1964) J Indian Med Assoc , vol.42 , pp. 564-567
    • Rao, A.V.1
  • 10
    • 0025038717 scopus 로고
    • Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive compulsive disorder
    • Chouinard G, Goodman W, Greist JH (1990) Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive compulsive disorder. Psychopharmacol Bull 26: 279-284
    • (1990) Psychopharmacol Bull , vol.26 , pp. 279-284
    • Chouinard, G.1    Goodman, W.2    Greist, J.H.3
  • 12
    • 0025294010 scopus 로고
    • Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine
    • Goodman WK, Price LH, Delgado PL, Krystal JH, Nagy LM, Rasmussen SA, et al (1990) Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Arch Gen Psychiatry 47: 577-585
    • (1990) Arch Gen Psychiatry , vol.47 , pp. 577-585
    • Goodman, W.K.1    Price, L.H.2    Delgado, P.L.3    Krystal, J.H.4    Nagy, L.M.5    Rasmussen, S.A.6
  • 13
    • 0344532728 scopus 로고
    • Fluvoxamine treatment of obsessive-compulsive disorder
    • Florence, Italy
    • Greist JH (1991) Fluvoxamine treatment of obsessive-compulsive disorder. Presented at the 5th World Congress of Biological Psychiatry, Florence, Italy
    • (1991) 5th World Congress of Biological Psychiatry
    • Greist, J.H.1
  • 15
    • 0022612567 scopus 로고
    • An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder
    • Fontaine R, Chouinard G (1986) An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder. J Clin Psychopharmacol 6: 98-101
    • (1986) J Clin Psychopharmacol , vol.6 , pp. 98-101
    • Fontaine, R.1    Chouinard, G.2
  • 20
    • 0003361529 scopus 로고
    • CGI: Clinical global impressions
    • Guy E (ed) NIMH, Rockville, MD
    • National Institute of Mental Health (1976) CGI: Clinical global impressions. In: Guy E (ed) ECDEU Assessment for Psychopharmacology, Rev. edn. NIMH, Rockville, MD, pp 217-222
    • (1976) ECDEU Assessment for Psychopharmacology, Rev. Edn. , pp. 217-222
  • 25
    • 0023742740 scopus 로고
    • The evidence for 20 mg a day of fluoxetine as the optimal daily dose in the treatment of depression
    • Altamura AC, Montgomery SA, Wernicke JF (1988) The evidence for 20 mg a day of fluoxetine as the optimal daily dose in the treatment of depression. Br J Psychiatry 153: 109-112
    • (1988) Br J Psychiatry , vol.153 , pp. 109-112
    • Altamura, A.C.1    Montgomery, S.A.2    Wernicke, J.F.3
  • 27
    • 0028903368 scopus 로고
    • Fluoxetine: An overview of its pharmacodynamic and pharmacokinetic properties and review of its therapeutic efficacy in obsessive-compulsive disorder
    • Fulton B, McTavish D (1995) Fluoxetine: An overview of its pharmacodynamic and pharmacokinetic properties and review of its therapeutic efficacy in obsessive-compulsive disorder. CNS Drugs 3: 305-322
    • (1995) CNS Drugs , vol.3 , pp. 305-322
    • Fulton, B.1    McTavish, D.2
  • 28
    • 0026650332 scopus 로고
    • The safety of antidepressants
    • de Jonghe F, Swinkels JA (1992) The safety of antidepressants. Drugs 43: 40-47
    • (1992) Drugs , vol.43 , pp. 40-47
    • De Jonghe, F.1    Swinkels, J.A.2
  • 29
    • 0029925952 scopus 로고    scopus 로고
    • Treatment of obsessive-compulsive disorder with fluvoxamine: A multi-center, double-blind placebo-controlled trial
    • Goodman WK, Kozak MJ, Liebowitz M, White KL (1996) Treatment of obsessive-compulsive disorder with fluvoxamine: A multi-center, double-blind placebo-controlled trial. Int Clin Psychopharmacol 11: 21-29
    • (1996) Int Clin Psychopharmacol , vol.11 , pp. 21-29
    • Goodman, W.K.1    Kozak, M.J.2    Liebowitz, M.3    White, K.L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.